This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Wex Pharmaceuticals Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations in Neuropathic Pain Treatment by Susan Lu
Introduction
Susan Lu is an accomplished inventor based in Vancouver, Canada. She has made significant contributions to the field of medical science, particularly in the treatment of neuropathic pain associated with chemotherapy. Her innovative approach has the potential to improve the quality of life for many patients suffering from this debilitating condition.
Latest Patents
Susan Lu holds a patent for the "Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy." This patent describes the use of sodium channel blockers, such as tetrodotoxin or saxitoxin, along with their analogs, derivatives, and acceptable salts, for treating neuropathic pain resulting from chemotherapy. The patent outlines various methods, compositions, dose units, and dose forms related to the use of tetrodotoxin.
Career Highlights
Throughout her career, Susan Lu has demonstrated a strong commitment to advancing medical research and innovation. She is currently associated with Wex Pharmaceuticals Inc., where she continues to explore new therapeutic avenues for pain management. Her work has garnered attention in the scientific community, highlighting her role as a leading inventor in her field.
Collaborations
Susan Lu has collaborated with notable professionals in her field, including Helmut Heinrich Buschmann and Jose Miguel Vela Hernandez. These collaborations have enriched her research and contributed to the development of her innovative solutions.
Conclusion
Susan Lu's contributions to the treatment of neuropathic pain through her patented innovations exemplify the impact of dedicated inventors in the medical field. Her work not only addresses a critical health issue but also paves the way for future advancements in pain management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile